We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MTNB market cap is 3.41M. The company's latest EPS is USD -4.7673 and P/E is -0.14.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.89M | -5.9M | -5.84M | -4.38M | -6.13M |
| Net Income | -5.31M | -5.82M | -5.72M | -4.28M | -8.43M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 158k | 33k | 3.19M | 1.1M | 0 |
| Operating Income | -24.21M | -24.74M | -24.59M | -23.77M | -22.26M |
| Net Income | -23.24M | -23.68M | -21M | -22.94M | -24.25M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.1M | 19.61M | 24.37M | 20.58M | 12.64M |
| Total Liabilities | 5.86M | 5.05M | 5.26M | 4.8M | 5.05M |
| Total Equity | 19.25M | 14.56M | 19.1M | 15.78M | 7.59M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 70.97M | 61.33M | 44.82M | 25.1M | 12.64M |
| Total Liabilities | 7.24M | 8.83M | 8.18M | 5.86M | 5.05M |
| Total Equity | 63.73M | 52.49M | 36.64M | 19.25M | 7.59M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.28M | -5.77M | -8.88M | -12.38M | -15.89M |
| Investing | 13.24M | 2M | -938k | 8.71M | 9.21M |
| Financing | -7k | 53k | 9.24M | 9.18M | 9.17M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.37M | -15.22M | -19.16M | -15.28M | -15.89M |
| Investing | -40.67M | 16.77M | 4.88M | 13.24M | 9.21M |
| Financing | 48.05M | 6.97M | 79k | -7k | 9.17M |
| Market Cap | 3.41M |
| Price to Earnings Ratio | -0.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.46 |
| Price to Book Ratio | 0.44 |
| Dividend Yield | - |
| Shares Outstanding | 5.09M |
| Average Volume (1 week) | 19.69k |
| Average Volume (1 Month) | 29.2k |
| 52 Week Change | -92.56% |
| 52 Week High | 9.72 |
| 52 Week Low | 0.4748 |
| Spread (Intraday) | 0.03 (4.55%) |
| Company Name | Matinas Biopharma Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.matinasbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
